Background—Antithrombotic therapy for intracranial arterial stenosis was recently evaluated
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …

Atherosclerotic disease of the major intracranial arteries is a frequent cause of stroke. In
addition, many patients who have symptomatic intracranial stenosis are at very high risk for …

Background: The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial showed
that patients with symptomatic 70% to 99% intracranial arterial stenosis are at particularly …

Purpose Basilar artery stenosis (BAS) carries high morbidity and mortality, with variable
outcomes after endovascular treatments. We systematically reviewed the literature on …

Objective—To assess the safety and clinical efficacy of stenting for patients with symptomatic
M1 stenosis of middle cerebral artery (MCA), and to assess the significance of classification …

Background Blindness is a rare but catastrophic complication of facial hyaluronic acid (HA)
injection. Although various means to rescue visual impairment have been employed, no …

Background: Endovascular revascularization for intracranial atherosclerotic stenoses is
being increasingly performed at major medical centers and has been reported to be …

Background and Purpose—Although extracranial carotid artery disease (ECAD) is accepted
as a risk factor for central nervous system (CNS) complications after coronary artery bypass …

Object. Medically refractory, symptomatic atherosclerotic disease of the basilar artery (BA)
portends a poor prognosis. Studies have shown morbidity rates following placement of …

Object. Medically refractory symptomatic vertebrobasilar atherosclerotic disease has a poor
prognosis. Studies have shown that longer (≥ 10 mm), eccentric, high-grade (> 70%) …